Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

November 5, 2013

Jason S. Nardiello Joins Hiscock & Barclay as Partner

Syracuse, New York - November 5, 2013 - Jason S. Nardiello has joined Hiscock & Barclay, LLP as a Partner in the firm's Intellectual Property Practice Area. He will work in the Syracuse office.

A graduate of New York Law School and The College of New Jersey, Nardiello has extensive experience as lead trial attorney on high-stakes trademark and copyright cases involving famous brand names and has counseled Fortune 500 companies to help them protect and enforce their worldwide trademark portfolios.

Nardiello comes to Hiscock & Barclay from Locke Lord LLP in New York where he focused on intellectual property matters. He has also worked in entertainment law and commercial litigation. Nardiello was named a Rising Star by Super Lawyers for 2012-2013.

Hiscock & Barclay, LLP, listed as a "Top 250 Firm" by The National Law Journal, is a full-service, 200-attorney law firm, with offices throughout the major cities of New York State, as well as in Boston, Washington, Newark, N.J. and Toronto, providing comprehensive legal and business counsel to a diverse client base in 30 practice areas.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

NYS Governor Hochul's 2026 State of the State Address Signals Continued Focus on Nuclear Development, Announces Additional 4 GW Target

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 2

Alerts

College Sports Commission Issues Notice Regarding Violations Arising From Third-Party NIL Deals

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Antoinette Suchenko, Jared Charlap, Adrienne Beatty, Tracey Sinkovic, Dominick Petrillo, and Sofia Montano—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Second Department Holds CVA Plaintiff's Testimony of Repeated Classroom Abuse Sufficient to Raise Question of Fact as to Notice

Alerts

Shifting Drug Pricing Models: Independent Pharmacies Need to Develop Compliance Strategies Now